Comparative Analysis of Financial Performance Before The Pandemic and During

Abstract

In 2020, the corona virus that hit China has spread throughout the country, causing a worldwide pandemic. Global pandemic conditions will certainly affect financial performance in every industrial sector and an example is the pharmaceutical industry. The pharmaceutical industry has different financial performance conditions in response to the impact of the pandemic, including the pharmaceutical industry in Indonesia. Thus the purpose of this study was to compare the financial performance of the period before the pandemic and during the pandemic used in this study were pharmaceutical companies registered in Indonesia. The research method used is comparative quantitative. This study uses secondary data by utilizing financial reports. The number of samples is 10 go public firms of pharmaceutical companies on the Indonesian Stock Exchange (IDX). The documentation method is used to collect data. The analytical tool used in this study is to use liquidity ratios, solvency ratios, activity ratios and profitability ratios which are tested differently with the pair sample t-test. Based on the results of different tests with the pair sample t-test, it was found that differences in financial performance before and during the pandemic indicated by the ratio of total asset turnover had significant differences in financial performance, while the debt to equity ratio, current ratio, and net profit margin did not show any differences in financial performance significant.